BsAb Armed-T therapy platform

CytoArm created a bi-functional antibody (BsAb) Armed-T platform, a promising, non-viral technique to redirect T cells to target tumor cells. By armoring T cells with different BsAbs, CytoArm aims to lead various T cell therapies curing limitless cancers.